|
Name |
Butyl isobutyrate
|
Molecular Formula | C8H16O2 | |
IUPAC Name* |
butyl 2-methylpropanoate
|
|
SMILES |
CCCCOC(=O)C(C)C
|
|
InChI |
InChI=1S/C8H16O2/c1-4-5-6-10-8(9)7(2)3/h7H,4-6H2,1-3H3
|
|
InChIKey |
JSLCOZYBKYHZNL-UHFFFAOYSA-N
|
|
Synonyms |
Butyl isobutyrate; 97-87-0; Butyl 2-methylpropanoate; Butyl isobutanoate; Propanoic acid, 2-methyl-, butyl ester; Isobutyric acid, butyl ester; n-Butyl isobutyrate; BUTYLISOBUTYRATE; FEMA No. 2188; PW9UJ5C0F3; Isobutyric acid n-butyl ester; Butyl ester of 2-methylpropanoic acid; Butyl isobutyrate; n-Butyl isobutyrate; Butyl isobutyrate (natural); EINECS 202-614-6; UNII-PW9UJ5C0F3; Isobutyric Acid Butyl Ester; AI3-24261; Isobutyric acid, butyl ester (6CI,7CI,8CI); Isobutyric acid butyl; n-Butyl iso-butyrate; butyl 2-methyl propanoate; Butyl 2-methylpropanoate #; SCHEMBL407053; Isobutyric acid n- butyl ester; BUTYL ISOBUTYRATE [FCC]; BUTYL ISOBUTYRATE [FHFI]; DTXSID9073888; FEMA 2188; CHEBI:179935; 2-methylpropanoic acid butyl ester; ZINC2041165; MFCD00048773; AKOS015839712; Butyl isobutyrate, natural, 97%, FG; Butyl isobutyrate, >=97%, FCC, FG; AS-77385; FT-0623333; I0315; F72102; Q27286785
|
|
CAS | 97-87-0 | |
PubChem CID | 7353 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 144.21 | ALogp: | 2.4 |
HBD: | 0 | HBA: | 2 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 26.3 | Aromatic Rings: | 0 |
Heavy Atoms: | 10 | QED Weighted: | 0.448 |
Caco-2 Permeability: | -4.177 | MDCK Permeability: | 0.00002950 |
Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.945 |
30% Bioavailability (F30%): | 0.96 |
Blood-Brain-Barrier Penetration (BBB): | 0.972 | Plasma Protein Binding (PPB): | 50.39% |
Volume Distribution (VD): | 1.011 | Fu: | 62.52% |
CYP1A2-inhibitor: | 0.925 | CYP1A2-substrate: | 0.687 |
CYP2C19-inhibitor: | 0.41 | CYP2C19-substrate: | 0.857 |
CYP2C9-inhibitor: | 0.161 | CYP2C9-substrate: | 0.414 |
CYP2D6-inhibitor: | 0.018 | CYP2D6-substrate: | 0.285 |
CYP3A4-inhibitor: | 0.026 | CYP3A4-substrate: | 0.278 |
Clearance (CL): | 8.668 | Half-life (T1/2): | 0.713 |
hERG Blockers: | 0.037 | Human Hepatotoxicity (H-HT): | 0.016 |
Drug-inuced Liver Injury (DILI): | 0.295 | AMES Toxicity: | 0.008 |
Rat Oral Acute Toxicity: | 0.035 | Maximum Recommended Daily Dose: | 0.011 |
Skin Sensitization: | 0.299 | Carcinogencity: | 0.126 |
Eye Corrosion: | 0.95 | Eye Irritation: | 0.982 |
Respiratory Toxicity: | 0.21 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000726 | 0.833 | D0ZK8H | 0.314 | ||||
ENC000186 | 0.586 | D01QLH | 0.297 | ||||
ENC000602 | 0.567 | D0AY9Q | 0.283 | ||||
ENC001137 | 0.543 | D05PLH | 0.281 | ||||
ENC000570 | 0.525 | D0Q9HF | 0.275 | ||||
ENC000819 | 0.500 | D0U7BW | 0.275 | ||||
ENC000645 | 0.488 | D0Y3KG | 0.268 | ||||
ENC000718 | 0.487 | D02KBD | 0.264 | ||||
ENC000245 | 0.472 | D00WUF | 0.256 | ||||
ENC000187 | 0.457 | D08HQK | 0.254 |